{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T18:52:06Z","timestamp":1791139926713,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Translational Research"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1016\/j.trsl.2010.09.005","type":"journal-article","created":{"date-parts":[[2010,10,22]],"date-time":"2010-10-22T11:07:03Z","timestamp":1287745623000},"page":"10-18","source":"Crossref","is-referenced-by-count":51,"title":["Tumor necrosis factor-\u03b1 blockade, cardiovascular outcomes, and survival in rheumatoid arthritis"],"prefix":"10.1016","volume":"157","author":[{"given":"Ziyad","family":"Al-Aly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelique","family":"Zeringue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Xian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay R.","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarek M.","family":"El-Achkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seth","family":"Eisen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trsl.2010.09.005_bib1","doi-asserted-by":"crossref","unstructured":"Huizinga TW, Pincus T. In the clinic. Rheumatoid arthritis. Ann Intern Med 153:ITC1\u2013ITC-15; quiz ITC1\u2013ITC6.","DOI":"10.7326\/0003-4819-153-1-201007060-01001"},{"key":"10.1016\/j.trsl.2010.09.005_bib2","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1056\/NEJMct055183","article-title":"Tumor necrosis factor inhibitors for rheumatoid arthritis","volume":"355","author":"Scott","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trsl.2010.09.005_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/187152907780059047","article-title":"Medial vascular calcification in diabetes mellitus and chronic kidney disease: the role of inflammation","volume":"7","author":"Al-Aly","year":"2007","journal-title":"Cardiovasc Hematol Disord Drug Targets"},{"key":"10.1016\/j.trsl.2010.09.005_bib4","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.trsl.2007.12.005","article-title":"Arterial calcification: a tumor necrosis factor-alpha mediated vascular Wnt-opathy","volume":"151","author":"Al-Aly","year":"2008","journal-title":"Transl Res"},{"key":"10.1016\/j.trsl.2010.09.005_bib5","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1053\/j.arrt.2004.04.006","article-title":"Vascular biology in uremia: insights into novel mechanisms of vascular injury","volume":"11","author":"Al Aly","year":"2004","journal-title":"Adv Chronic Kidney Dis"},{"key":"10.1016\/j.trsl.2010.09.005_bib6","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1053\/j.ackd.2008.07.011","article-title":"Vascular calcification in uremia: what is new and where are we going?","volume":"15","author":"Al-Aly","year":"2008","journal-title":"Adv Chronic Kidney Dis"},{"key":"10.1016\/j.trsl.2010.09.005_bib7","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1517\/14656566.9.7.1121","article-title":"Cardiovascular risk in rheumatoid arthritis: effects of anti-TNF drugs","volume":"9","author":"Avouac","year":"2008","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.trsl.2010.09.005_bib8","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1196\/annals.1422.036","article-title":"Accelerated atherosclerosis in rheumatoid arthritis","volume":"1108","author":"Szekanecz","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.trsl.2010.09.005_bib9","doi-asserted-by":"crossref","first-page":"285","DOI":"10.2174\/157016110790886965","article-title":"Potential effect of anti-tumour necrosis factor-alpha treatment on reducing the cardiovascular risk related to rheumatoid arthritis","volume":"8","author":"Cugno","year":"2010","journal-title":"Curr Vasc Pharmacol"},{"key":"10.1016\/j.trsl.2010.09.005_bib10","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1161\/ATVBAHA.107.153668","article-title":"Aortic Msx2-Wnt calcification cascade is regulated by TNF-alpha-dependent signals in diabetic Ldlr-\/- mice","volume":"27","author":"Al-Aly","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.trsl.2010.09.005_bib11","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1136\/hrt.2009.171561","article-title":"Disease-modifying anti-rheumatic drugs: do they reduce cardiac complications of RA?","volume":"95","author":"Hamdulay","year":"2009","journal-title":"Heart"},{"key":"10.1016\/j.trsl.2010.09.005_bib12","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1136\/ard.2006.063867","article-title":"What effects might anti-TNFalpha treatment be expected to have on cardiovascular morbidity and mortality in rheumatoid arthritis? A review of the role of TNFalpha in cardiovascular pathophysiology","volume":"66","author":"Dixon","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.trsl.2010.09.005_bib13","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1197\/jamia.M1548","article-title":"Informatics resources to support health care quality improvement in the Veterans Health Administration","volume":"11","author":"Hynes","year":"2004","journal-title":"J Am Med Inform Assoc"},{"key":"10.1016\/j.trsl.2010.09.005_bib14","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1002\/art.20827","article-title":"Accuracy of Veterans Administration databases for a diagnosis of rheumatoid arthritis","volume":"51","author":"Singh","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.trsl.2010.09.005_bib15","unstructured":"U.S. Department of Veterans Affairs. VIReC research user guide: VHA Medical SAS\u00ae inpatient datasets FY2006. Hines, Ill: U.S. Department of Veterans Affairs, VA Information Resource Center; 2007."},{"key":"10.1016\/j.trsl.2010.09.005_bib16","unstructured":"U.S. Department of Veterans Affairs. VIReC research user guide: VHA Medical SAS\u00ae outpatient datasets FY2006. Hines, Ill: U.S. Department of Veterans Affairs, VA Information Resource Center; 2007."},{"key":"10.1016\/j.trsl.2010.09.005_bib17","unstructured":"U.S. Department of Veterans Affairs. VIReC research user guide: Veterans Health Administration pharmacy prescription data. 2nd ed. Hines, Ill: U.S. Department of Veterans Affairs, VA Information Resource Center; 2008."},{"key":"10.1016\/j.trsl.2010.09.005_bib18","first-page":"1679","article-title":"Performance of a rheumatoid arthritis records-based index of severity","volume":"32","author":"Ting","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.trsl.2010.09.005_bib19","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1136\/ard.2006.062760","article-title":"Time-dependent increase in risk of hospitalisation with infection among Swedish RA patients treated with TNF antagonists","volume":"66","author":"Askling","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.trsl.2010.09.005_bib20","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1002\/art.22600","article-title":"Anti-tumor necrosis factor alpha therapy and the risk of serious bacterial infections in elderly patients with rheumatoid arthritis","volume":"56","author":"Schneeweiss","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.trsl.2010.09.005_bib21","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1002\/art.22504","article-title":"Risk of serious bacterial infections among rheumatoid arthritis patients exposed to tumor necrosis factor alpha antagonists","volume":"56","author":"Curtis","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.trsl.2010.09.005_bib22","doi-asserted-by":"crossref","first-page":"4226","DOI":"10.1002\/art.23050","article-title":"Drug-specific and time-dependent risks of bacterial infection among patients with rheumatoid arthritis who were exposed to tumor necrosis factor alpha antagonists","volume":"56","author":"Curtis","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.trsl.2010.09.005_bib23","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1161\/01.CIR.0000124490.27666.B2","article-title":"Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL)","volume":"109","author":"Mann","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.trsl.2010.09.005_bib24","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0167-5273(02)00470-9","article-title":"How to RECOVER from RENAISSANCE? The significance of the results of RECOVER, RENAISSANCE, RENEWAL and ATTACH","volume":"86","author":"Anker","year":"2002","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.trsl.2010.09.005_bib25","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1161\/01.CIR.0000077913.60364.D2","volume":"107","author":"Chung","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.trsl.2010.09.005_bib26","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/BOR.0b013e3282fb03d8","article-title":"Biologics and heart failure in rheumatoid arthritis: are we any wiser?","volume":"20","author":"Danila","year":"2008","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.trsl.2010.09.005_bib27","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1002\/art.23280","article-title":"Tumor necrosis factor inhibition: a part of the solution or a part of the problem of heart failure in rheumatoid arthritis?","volume":"58","author":"Gabriel","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.trsl.2010.09.005_bib28","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s00296-006-0215-3","article-title":"The incidence of new onset congestive heart failure and heart failure exacerbation in Veteran\u2019s Affairs patients receiving tumor necrosis factor alpha antagonists","volume":"27","author":"Cole","year":"2007","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.trsl.2010.09.005_bib29","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ahj.2008.02.025","article-title":"Tumor necrosis factor-alpha antagonist use and heart failure in elderly patients with rheumatoid arthritis","volume":"156","author":"Setoguchi","year":"2008","journal-title":"Am Heart J"},{"key":"10.1016\/j.trsl.2010.09.005_bib30","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.amjmed.2003.09.039","article-title":"Heart failure in rheumatoid arthritis: rates, predictors, and the effect of anti-tumor necrosis factor therapy","volume":"116","author":"Wolfe","year":"2004","journal-title":"Am J Med"},{"key":"10.1016\/j.trsl.2010.09.005_bib31","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1136\/ard.2006.062497","article-title":"Treatment with TNF blockers and mortality risk in patients with rheumatoid arthritis","volume":"66","author":"Jacobsson","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.trsl.2010.09.005_bib32","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/ki.2008.563","article-title":"The new role of calcimimetics as vasculotropic agents","volume":"75","author":"Al-Aly","year":"2009","journal-title":"Kidney Int"},{"key":"10.1016\/j.trsl.2010.09.005_bib33","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/sj.ki.5002544","article-title":"Vitamin D as a novel nontraditional risk factor for mortality in hemodialysis patients: the need for randomized trials","volume":"72","author":"Al-Aly","year":"2007","journal-title":"Kidney Int"},{"key":"10.1016\/j.trsl.2010.09.005_bib34","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1681\/ASN.2009121210","article-title":"Rate of kidney function decline associates with mortality","volume":"21","author":"Al-Aly","year":"2010","journal-title":"J Am Soc Nephrol"}],"container-title":["Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524410002380?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524410002380?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,5]],"date-time":"2019-06-05T19:19:24Z","timestamp":1559762364000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1931524410002380"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["S1931524410002380"],"URL":"https:\/\/doi.org\/10.1016\/j.trsl.2010.09.005","relation":{},"ISSN":["1931-5244"],"issn-type":[{"value":"1931-5244","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]}}}